As of 2024-12-14, the EV/EBITDA ratio of Genovis AB (GENO.ST) is 46.30. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. GENO.ST's latest enterprise value is 1,620.90 mil SEK. GENO.ST's TTM EBITDA according to its financial statements is 35.01 mil SEK. Dividing these 2 quantities gives us the above GENO.ST EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 12.7x - 25.3x | 20.5x |
| Forward P/E multiples | 9.2x - 19.4x | 13.6x |
| Fair Price | 7.70 - 20.80 | 13.38 |
| Upside | -70.0% - -18.9% | -47.9% |
| Date | EV/EBITDA |
| 2024-12-11 | 45.64 |
| 2024-12-10 | 45.55 |
| 2024-12-09 | 45.55 |
| 2024-12-06 | 44.99 |
| 2024-12-05 | 43.21 |
| 2024-12-04 | 44.90 |
| 2024-12-03 | 44.24 |
| 2024-12-02 | 45.27 |
| 2024-11-29 | 47.42 |
| 2024-11-28 | 47.79 |
| 2024-11-27 | 45.74 |
| 2024-11-26 | 49.57 |
| 2024-11-25 | 50.22 |
| 2024-11-22 | 50.79 |
| 2024-11-21 | 49.20 |
| 2024-11-20 | 49.94 |
| 2024-11-19 | 50.04 |
| 2024-11-18 | 50.79 |
| 2024-11-15 | 49.76 |
| 2024-11-14 | 49.38 |
| 2024-11-13 | 47.89 |
| 2024-11-12 | 48.45 |
| 2024-11-11 | 48.35 |
| 2024-11-08 | 45.92 |
| 2024-11-07 | 35.73 |
| 2024-11-06 | 35.83 |
| 2024-11-05 | 38.72 |
| 2024-11-04 | 39.29 |
| 2024-11-01 | 39.01 |
| 2024-10-31 | 39.01 |
| 2024-10-30 | 39.57 |
| 2024-10-29 | 40.31 |
| 2024-10-28 | 39.66 |
| 2024-10-25 | 39.47 |
| 2024-10-24 | 39.85 |
| 2024-10-23 | 39.29 |
| 2024-10-22 | 40.22 |
| 2024-10-21 | 41.25 |
| 2024-10-18 | 40.97 |
| 2024-10-17 | 41.72 |
| 2024-10-16 | 41.16 |
| 2024-10-15 | 41.62 |
| 2024-10-14 | 42.28 |
| 2024-10-11 | 42.65 |
| 2024-10-10 | 42.56 |
| 2024-10-09 | 42.46 |
| 2024-10-08 | 43.12 |
| 2024-10-07 | 44.43 |
| 2024-10-04 | 45.08 |
| 2024-10-03 | 45.92 |